{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:21Z","timestamp":1791849621751,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004189","name":"Max-Planck-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.biocel.2010.10.014","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T08:53:13Z","timestamp":1288947193000},"page":"20-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Huntington's disease: From molecular basis to therapeutic advances"],"prefix":"10.1016","volume":"43","author":[{"given":"Sylvia","family":"Krobitsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksey G.","family":"Kazantsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2010.10.014_bib0005","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"HDCRG","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2010.10.014_bib0010","doi-asserted-by":"crossref","first-page":"328","DOI":"10.12968\/bjon.2008.17.5.28830","article-title":"Huntington's disease. Part 3: family aspects of HD","volume":"17","author":"Aubeeluck","year":"2008","journal-title":"Br J Nurs"},{"key":"10.1016\/j.biocel.2010.10.014_bib0015","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","article-title":"Huntingtin aggregation and toxicity in Huntington's disease","volume":"361","author":"Bates","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.biocel.2010.10.014_bib0020","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biocel.2010.10.014_bib0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2010.10.014_bib0030","doi-asserted-by":"crossref","first-page":"9773","DOI":"10.1523\/JNEUROSCI.3183-05.2005","article-title":"Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease","volume":"25","author":"Diaz-Hernandez","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.biocel.2010.10.014_bib0035","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","article-title":"Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons","volume":"14","author":"DiFiglia","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.biocel.2010.10.014_bib0040","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.biocel.2010.10.014_bib0045","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1523\/JNEUROSCI.11-12-03877.1991","article-title":"Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry","volume":"11","author":"Ferrante","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.biocel.2010.10.014_bib0050","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ng1093-174","article-title":"Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects","volume":"5","author":"Goldberg","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.biocel.2010.10.014_bib0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/14737175.1.1.111","article-title":"Neuroprotective therapy for Huntington's disease: new prospects and challenges","volume":"1","author":"Hersch","year":"2001","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.biocel.2010.10.014_bib0060","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.nurt.2008.01.003","article-title":"Neuroprotection for Huntington's disease: ready, set, slow","volume":"5","author":"Hersch","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biocel.2010.10.014_bib0065","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biocel.2010.10.014_bib0070","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1371\/journal.pgen.0030082","article-title":"Huntingtin interacting proteins are genetic modifiers of neurodegeneration","volume":"3","author":"Kaltenbach","year":"2007","journal-title":"PLoS Genet"},{"key":"10.1016\/j.biocel.2010.10.014_bib0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1358\/dnp.2007.20.8.1157616","article-title":"Cellular pathways leading to neuronal dysfunction and degeneration","volume":"20","author":"Kazantsev","year":"2007","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.biocel.2010.10.014_bib0080","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2681","article-title":"Therapeutic application of histone deacetylase inhibitors for central nervous system disorders","volume":"7","author":"Kazantsev","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biocel.2010.10.014_bib0085","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","article-title":"A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats","volume":"330","author":"Kremer","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biocel.2010.10.014_bib0090","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ana.410360604","article-title":"Trinucleotide repeat expansion in neurological disease","volume":"36","author":"La Spada","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biocel.2010.10.014_bib0095","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/nmeth.1261","article-title":"Linking SNPs to CAG repeat length in Huntington's disease patients","volume":"5","author":"Liu","year":"2008","journal-title":"Nat Methods"},{"key":"10.1016\/j.biocel.2010.10.014_bib0100","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.2174\/138161209789649295","article-title":"RNAi applications in therapy development for neurodegenerative disease","volume":"15","author":"Maxwell","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.biocel.2010.10.014_bib0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0896-6273(02)00761-4","article-title":"Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?","volume":"35","author":"Muchowski","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.biocel.2010.10.014_bib0110","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.biocel.2010.10.014_bib0115","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00415-006-0198-8","article-title":"Apoptotic cascades as possible targets for inhibiting cell death in Huntington's disease","volume":"253","author":"Pattison","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.biocel.2010.10.014_bib0120","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1345\/aph.1M582","article-title":"Role of tetrabenazine for Huntington's disease-associated chorea","volume":"44","author":"Poon","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.biocel.2010.10.014_bib0125","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1196\/annals.1427.034","article-title":"Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease?","volume":"1147","author":"Rosas","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biocel.2010.10.014_bib0130","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","article-title":"Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo","volume":"90","author":"Scherzinger","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2010.10.014_bib0135","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1093\/hmg\/ddm213","article-title":"Polyglutamine diseases: emerging concepts in pathogenesis and therapy","volume":"16","author":"Shao","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biocel.2010.10.014_bib0140","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biocel.2010.10.014_bib0145","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1111\/j.1742-4658.2008.06561.x","article-title":"Huntington's disease: revisiting the aggregation hypothesis in polyglutamine neurodegenerative diseases","volume":"275","author":"Truant","year":"2008","journal-title":"FEBS J"},{"key":"10.1016\/j.biocel.2010.10.014_bib0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272510003742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272510003742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T07:10:06Z","timestamp":1749539406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272510003742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1357272510003742"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2010.10.014","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Huntington's disease: From molecular basis to therapeutic advances","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2010.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}